Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry

BACKGROUND AND OBJECTIVE: Gastroesophageal reflux disease (GORD) is highly prevalent in idiopathic pulmonary fibrosis (IPF) and may play a role in its pathogenesis. Recent IPF treatment guidelines suggest that all patients with IPF be considered for antacid therapy. However, emerging evidence sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Helen E., Corte, Tamera J., Glaspole, Ian, Grainge, Christopher, Hopkins, Peter M. A., Moodley, Yuben, Reynolds, Paul N., Chapman, Sally, Walters, E. Haydn, Zappala, Christopher, Allan, Heather, Keir, Gregory J., Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samantha, Macansh, Sacha, Goh, Nicole S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499965/
https://www.ncbi.nlm.nih.gov/pubmed/31053121
http://dx.doi.org/10.1186/s12890-019-0846-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499965/
https://www.ncbi.nlm.nih.gov/pubmed/31053121
http://dx.doi.org/10.1186/s12890-019-0846-2

Ejemplares similares